Polarean Imaging PLC’s (LON:POLX) Richard Hullihen joins Proactive London’s Katie Pilbeam to discuss an article on hyper-polarised xenon.
The Oxford Biomedical Research Centre revealed the research, concerning a study carried out in longer-term lung damage after COVID-19.
This preliminary research determined that hyperpolarised xenon MRI scans had found abnormalities in the lungs of some COVID-19 patients more than three months - and in some cases, nine months - after leaving hospital, when other clinical measurements were normal.
